14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today EDGE ranks #18129 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Edge Therapeutics Stock Forecast NASDAQ:EDGE

$6.28 (-2.03%)

Volume: 317k

Closed: Jan 19, 2022

Hollow Logo Score: -6.013

Edge Therapeutics Stock Forecast

$6.28 (-2.03%)

Volume: 317k

Closed: Jan 19, 2022

Score Hollow Logo -6.013

Edge Therapeutics Company Profile

200 Connell Drive

Berkeley Heights NJ 07922



Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. The company was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE